6505--Droxidopa Capsules (VA-27-00007975)

MARKET RESEARCH QUESTIONNAIRE Droxidopa Capsules Company Name: _________________________ I am conducting market research for the procurement of Droxidopa Capsules, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies.� Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume.� These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following: Is your Company able to meet the following minimum requirements: National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)? _____________ If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________ Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________ Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs? _________ Under NAICS code 325412, is your company size (check one): Large Business ______ Small Business ______ If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered? ___________ If your company is not the manufacturer, is the manufacturer a small business concern, as defined in FAR Part 2 with an active SAM registration? ___________ Is the offered end product U.S-made, as defined in FAR Part 25? ___________ If not, if the offered product an end product of a Trade Agreements Act designated country, as defined in FAR Part 25? _________ Can your company meet the following product, bottle size and usage? Please indicate any details or comments. ______________________________________________________________ ______________________________________________________________ Item Description Package Size (Capsules per Bottle) Total Estimated Annual Usage (Bottles) 1 Droxidopa 100MG Capsules, ORAL 90 6,160 2 Droxidopa 200MG Capsules, ORAL 90 3,587 3 Droxidopa 300MG Capsules, ORAL 90 3,738 Is your Company interested in submitting a response to a solicitation?________ As this is a national standardized contract, our preference is for a base plus four option years to provide our customers with continuity and consistency of product by allowing for long-term committed purchases of your product. If interested, please indicate base year and how many option periods, not to exceed four._________________ If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date? ______________________________________________________________________ If your company is not interested in participating, please respond with the reason why.� This aids our market research for future procurements. ______________________________________________________________________ VA intends to require in the solicitation that proposed products are in unit of use package sizes for all line items (90-count bottles). VA defines unit of use package sizes as follows: Unit of use package sizes must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Please indicate if your company can provide the products above meeting these packaging requirements. _______________________________________________________________________ If your company could supply the products in this solicitation in 90-count bottles, but could not meet the unit of use requirements outlined above, please use the space below to indicate the reason and any details. This information is important as it helps the Government consider possible product issues when developing the solicitation. _______________________________________________________________________ _______________________________________________________________________ If you could provide your responses by next Friday, September 4, 2026, it would be greatly appreciated. Please contact me at Andrew.Cazares@va.gov if you have any questions.